Recent trials focusing on stem cell therapies for treating Parkinson’s disease have shown promising early results. Current treatments can relieve symptoms, but there are no approved therapies to slow the disease’s progression. Two studies by BlueRock Therapeutics and Kyoto University are developing lower side-effect treatments, replacing lost dopamine-creating brain cells with stem cells. While the results are preliminary, they give hope that stem cell therapy could potentially advance therapeutic interventions for Parkinson’s patients.
An $8.4 billion money launderer has been operating for years on US soil
Research by Elliptic revealed a plethora of illegal activities on the cryptocurrency-based marketplace, Xinbi Guarantee. The platform is said to be a haven for scams,
